Ultrasound has emerged as a valuable tool for evaluating inflammatory bowel disease (IBD), offering a non-invasive, radiation-free method for assessing disease activity, complications, and treatment response. This article focuses on the sonographic features of Crohn’s disease and ulcerative colitis, the two main forms of IBD.

Key Advantages of Ultrasound in IBD:

• No ionizing radiation: Important for young patients requiring repeated imaging.
• Real-time assessment: Allows evaluation of peristalsis and compressibility.
• Extramural evaluation: Useful for identifying complications like abscesses and fistulas.
• Accessibility: Bedside availability and low cost.
• Interventional utility: Ability to guide biopsies or drainage procedures.

1. Crohn’s Disease

A chronic transmural inflammatory condition that can affect any part of the gastrointestinal tract, most commonly the terminal ileum and colon.

Pathological Features

• Skip lesions with normal intervening bowel.
• Transmural inflammation leading to strictures and fistulas.
• Mesenteric fat hypertrophy (“creeping fat”).
• Lymphoid hyperplasia and granuloma formation.

Ultrasound Findings

• Bowel wall thickening: >3mm in small bowel, >4mm in colon.
• Stratification loss: Disruption of normal wall layers.
• Mesenteric fat hypertrophy: Hyperechoic fat surrounding bowel.
• Increased vascularity: Detected on color Doppler (active inflammation).
• Strictures: Prestenotic dilation, reduced peristalsis.
• Fistulas and abscesses: Hypoechoic tracts or collections.

2. Ulcerative Colitis

A chronic mucosal inflammatory condition limited to the colon, always starting in the rectum and extending proximally in a continuous fashion.

Pathological Features

• Continuous mucosal inflammation (no skip lesions).
• Superficial ulcers and pseudopolyps.
• Mucosal atrophy in chronic disease.
• No transmural inflammation or fistulas.

Ultrasound Findings

• Colonic wall thickening: Typically 5-10mm in active disease.
• Preserved stratification: Unlike Crohn’s, layers are usually maintained.
• Mucosal irregularity: Pseudopolyps and ulcers.
• Pericolic fat inflammation: Mild compared to Crohn’s.
• Haustra loss: Seen in chronic cases.
• Backwash ileitis: Terminal ileum involvement in pancolitis.

3. Disease Activity Assessment

Ultrasound helps differentiate active inflammation from chronic fibrotic changes, guiding treatment.

Features Suggesting Active Inflammation

• Increased vascularity on color Doppler.
• Hypoechoic wall thickening (edema).
• Perienteric fat inflammation (hyperechoic fat).
• Lymph nodes enlargement (short axis >5mm).
• Free fluid adjacent to affected bowel.

Features Suggesting Chronic/Fibrotic Disease

• Hyperechoic wall thickening (fibrosis).
• Strictures without hyperemia.
• Reduced peristalsis.
• Prestenotic dilation.
• Absence of vascularity in thickened segments.

4. IBD Complications

Ultrasound is particularly valuable for detecting extramural complications.

• Abscesses: Hypo/anechoic collections with thick walls; may contain debris or gas.
• Fistulas: Hypoechoic tracts connecting bowel to other structures; may show gas bubbles.
• Strictures: Fixed luminal narrowing with prestenotic dilation; reduced/absent peristalsis.
• Toxic megacolon (in UC): Colonic dilation >6cm, thin featureless walls, absent haustration.

5. Differential Diagnosis

Condition	Key Differentiating Features
Infectious colitis	Often more diffuse, no fat wrapping, clinical history
Diverticulitis	Focal pericolonic inflammation, diverticula present
Ischemic colitis	Segmental, reduced vascularity, clinical context
Lymphoma	Marked hypoechoic thickening, no hyperemia
Tuberculosis	Ileocecal involvement, necrotic lymph nodes
NSAID enteropathy	Diaphragm-like strictures, no fat wrapping

Diagnostic Tip: The combination of bowel wall thickening, mesenteric fat hypertrophy, and skip lesions is highly suggestive of Crohn’s disease. Continuous involvement from rectum proximally favors ulcerative colitis.

References

1. Maconi G, et al. EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases. Ultraschall Med. 2018;39(3):304-317.
2. Nylund K, et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med. 2017;38(3):e1-e15.
3. Panes J, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7(7):556-585.
4. Kucharzik T, et al. Ultrasound in Inflammatory Bowel Disease - So Far We Are? Clin Gastroenterol Hepatol. 2022;20(1):1-12.
5. Allocca M, et al. Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity. Clin Gastroenterol Hepatol. 2017;15(4):535-542.
6. Maaser C, et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut. 2020;69(9):1629-1636.
7. Ripollés T, et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions. Eur J Radiol. 2013;82(10):e525-e531.
8. Dietrich CF, et al. Ultrasound of the colon in inflammatory bowel disease. World J Gastroenterol. 2021;27(20):2473-2495.
9. Rumack CM, Levine D. Diagnostic Ultrasound. 5th ed. Elsevier; 2018.
10. American Institute of Ultrasound in Medicine (AIUM). AIUM practice guideline for the performance of gastrointestinal ultrasound examination. J Ultrasound Med. 2021;40(5):895-903.